ClinicalTrials.govpublic full text
Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer
melanoma, head and neck cancer, non small cell lung cancer, urothelial carcinoma, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 1030012
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.